176
Participants
Start Date
July 25, 2005
Primary Completion Date
March 28, 2008
Study Completion Date
March 28, 2008
Deferasirox
20 mg/kg/day over one year in patients with MDS
Rochester General Hospital/Lipson Cancer and Blood Center, Rochester
Roswell Park Cancer Center, Buffalo
Western Pennsylvania Hospital Cancer Institute, Pittsburgh
Thomas Jefferson University; Jefferson Medical College, Kimmel Cancer Center, Philadelphia
Arlington Fairfax Hematology Oncology PC, Arlington
Cancer Care of WNC, Asheville
Emory University School of Medicine/Winship Cancer Institute, Atlanta
Mayo Clinic, Jacksonville
Univ of Alabama Birmingham, Birmingham
Novartis Investigative site, Nashville
The West Cancer Clinic, Memphis
The Ohio State University, Columbus
The Cleveland Clinic Foundation, Cleveland
Novartis Investigative Site, Southfield
Medical College of Wisconsin, Milwaukee
Mayo Clinic, Rochester
Novartis Investigative Site, Chicago
The Center for Cancer Care & Research (TCCCR), St Louis
University of Kansas Medical Center, Kansas City
Cabrini Center for Cancer Care/Christus St. Frances Cabrini Hospital, Alexandria
Baylor/The Methodist Hospital, Houston
Rocky Mountain Cancer Centers, Aurora
Utah Cancer Specialists, Salt Lake City
Mayo Clinic, Phoenix
NMOHC, Albuquerque
Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles
City of Hope National Medical Center, Duarte
UCSF, San Francisco
Bay Area Cancer Research Group, Concord
Straub Clinic and Hospital, Honolulu
Novartis Investigative Site, Portland
Novartis Investigative Site, Spokane
UCLA Medical Center, Los Angeles
UCSF, San Francisco
University of Chicago Hospital, Chicago
University of Kentucky College of Medicine, Markey Cancer Center, Lexington
St. Agnes HealthCare, Baltimore
Rush Cancer Institute Univ. of Massachussets Medical Center, Worcester
Oncology Hematology West, PC, Omaha
Dartmouth Hitchcock Medical Center, Lebanon
The Cancer Center at Hackensack University, Hackensack
Wake Forest UniversitComprehensive Cancer Center, Winston-Salem
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY